We submit herewith the confirmation certificate received from M/s Bigshare Services Private Limited, RTA as per Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018 for the quarter ended 31st March, 2025.

pdf

Ishita Drugs & Industries Ltd.

19 Mar 2025

82.30

-0.45%

SAST

Ishita Drugs & Industries Ltd - 524400 - Closure of Trading Window

BSE India

The Trading window for dealing in securities of the Company by Designated Persons stands closed from Tuesday, 1st April, 2025 till 48 hours after the declaration of the Audited Financial Results for the quarter and financial year ended 31st March, 2025

pdf

Ishita Drugs & Industries Ltd.

01 Mar 2025

82.30

-0.45%

Company Update

ISHITA DRUGS & INDUSTRIES LTD. - 524400 - Disclosure Under Regulation 29(2) Of SEBI (Substantial Acquisition …

BSE India

Disclosure under regulation 29(2) of SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011 received from Jagdish Agrawal

pdf

Ishita Drugs & Industries Ltd.

13 Feb 2025, 06:02PM

82.30

-0.45%

Corp. Note

ISHITA DRUGS & INDUSTRIES LTD. - 524400 - Integrated Filing (Financial)

BSE India

Integrated Filing (Financials) for the quarter and nine months ended 31st December, 2024.

pdf

Ishita Drugs & Industries Ltd.

13 Feb 2025, 05:57PM

82.30

-0.45%

Result

ISHITA DRUGS & INDUSTRIES LTD. - 524400 - Outcome Of Board Meeting Held On 13Th February, …

BSE India

Approval of the Unaudited Financial Results of the Company for the quarter ended 31st December, 2024, the limited review report issued by statutory auditor of the company attached herewith.

pdf

Ishita Drugs & Industries Ltd.

13 Feb 2025, 05:49PM

82.30

-0.45%

Board Meeting

ISHITA DRUGS & INDUSTRIES LTD. - 524400 - Board Meeting Outcome for Outcome Of Board Meeting …

BSE India

Board of Directors of Ishita Drugs and Industries Limited, at its meeting held today i.e.13th February, 2025 have 1. Approved the Unaudited Financial Results of the Company for the quarter and nine months ended 31st December, 2024. and the Limited Review Report issued by the Statutory Auditors of the Company enclosed herewith.

pdf

Ishita Drugs & Industries Ltd.

06 Feb 2025

82.30

-0.45%

Board Meeting

ISHITA DRUGS & INDUSTRIES LTD. - 524400 - Board Meeting Intimation for Intimation Of Board Meeting …

BSE India

ISHITA DRUGS & INDUSTRIES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/02/2025 ,inter alia, to consider and approve 1. To consider, approve and take on record the Unaudited Financial Results of the Company for the quarter ended 31st December, 2024. 2. Any other matter with permission of the Chair.

pdf

Ishita Drugs & Industries Ltd.

13 Jan 2025, 01:43PM

82.30

-0.45%

Company Update

ISHITA DRUGS & INDUSTRIES LTD. - 524400 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) …

BSE India

we submit herewith the confirmation certificate received from M/s Bigshare Services Private Limited, RTA as per Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018 for the quarter ended 31st December, 2024.

pdf